Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Principal Investigator
Name
Omar Abdel-Rahman
Degrees
MD
Institution
Avicenna Oncology center
Position Title
Consultant and scientific director
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-417
Initial CDAS Request Approval
Nov 7, 2018
Title
Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial
Summary
A number of etiological factors which contribute to the development of lung cancer (e.g. smoking) might also predispose to the development of second primary cancers. Previous studies evaluating this research question were based on restrospectove registry-based analyses (e.g. SEER database). It is important to try to answer the same question in the context of prospectively collected dataset (like the PLCO trial dataset).
Aims

1. To determine the frequency of second primary cancers commonly developing among patients initially diagnosed with lung cancer.
2. To determine the factors associated with a higher risk of second primary malignancy development.

Collaborators

Dr. Omar Abdel-Rahman

Related Publications